The effect of halothane anaesthesia and neuroleptanalgesia (NLA) on the phagocytic activity of the reticulo-endothelial system (RES) was investigated with the aid of the Lipofundin clearance test. The results suggest that halothane in nitrous oxide depresses the phagocytic activity of the RES. NLA did not exert a depressant effect on the RES function. As it is essential for the body to be in a defensive condition to cope adequately with infection and cancer metastases, care must be taken to ensure that an anaesthetic procedure does not cause additional impairment of RES function. The results of the investigations suggest that NLA may have advantages in this respect.
The observation that storage takes place in the reticular tissue and in endothelial cells in lymph nodes and bone marrow (Ufer cells, sinus cells), in the liver (Kupffer cells) and probably also in the adrenal cortex sooner than in any other tissue led Aschoff (1924) to speak of the reticulo-endothelial system (RES) as acting in defence.
The function of the RES is of decisive importance in many diseases and tests of its function may be of value in diagnosis.
The reduction in RES function produced by surgery, which has been demonstrated both in animals (Saba and DiLucio, 1969) and in man (Donovan, 1967) , increases the body's susceptibility to attack by bacteria and toxic substances, constituting an added risk to any patient undergoing surgery.
A reduction in the phagocytic activity of the RES has been observed during anaesthesia, and this has been attributed to halothane (Lemperle, Denk and Reichelt, 1971) . RES function has also been investigated during anaesthesia involving other agents and methods (Lofstrom and Schildt, 1974) . Again, a reduction in the phagocytic activity of the RES was observed.
Since 1961, preference has been given to neuroleptanalgesia (NLA) in our department in the management of the elderly, those in poor general health and, in particular, patients with hepatic disorders. Our aim was to compare these two anaesthetic procedures by determining the function of the RES.
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anaesthesia. Fifteen patients were operated on under halothane-nitrous oxide anaesthesia and another 15 under NLA, all 30 receiving the same premedication.
PATIENTS AND METHODS
Thirty male surgical inpatients aged between 18 and 67 yr were studied. Fifteen patients (Group A) received halothane-nitrous oxide in oxygen anaesthesia, and 15 (Group B) received NLA.
All received phenobarbitone 100 mg orally and promethazine 25 mg i.m. on the evening before anaesthesia, piritramide 15 mg and promethazine 25 mg i.m. 60 min before anaesthesia and atropine 0.5 mg i.v. shortly before the induction of anaesthesia.
Group A
Twelve patients received thiopentone 5 mg/kg, halothane (0.7-1.0% v/v) in nitrous oxide in oxygen. Three patients received fentanyl 0.15 mg, etomidate 0.3 mg/kg and a gas mixture the same as above.
A mixture of oxygen and nitrous oxide in the proportion 1 :2 in the induction phase and 2:4 during the operation was used to assist ventilation.
Group B
Dehydrobenzperidol (DHB) 5 mg, fentanyl 0.5 mg, etomidate 0.1-0.15 mg/kg and pancuronium 4-6 mg were administered i.v. in succession; immediately afterwards a mixture of oxygen and nitrous oxide in the proportion 2 : 4 was supplied. Endotracheal intubation was performed after about 2.5 min. An interval of 3-5 min was allowed after the administration of DHB. Where the patient was in poor general health, particularly in the presence of cardiovascular disease, DHB was not given until shortly before the operation was commenced, after endotracheal intubation.
RES function test
The soya bean oil emulsion Lipofundin S 20 (Messrs Braun-Melsungen) was used as the test substance. Lipofundin S 20 is available in bottles of 100 ml with the following composition: To prepare for the test, 0.4 ml of a 3.8% sodium citrate solution was drawn up into each of eight 2-ml syringes. Physiological saline passed through a threeway tap was used to rinse the syringe between the collection of each blood sample.
Each patient was given an average dose of about 50 ml of Lipofundin S 20 i.v. exactly 2 min after a blood sample had been taken for the determination of the initial value. Blood samples 1.6 ml were then taken from the same arm at intervals, first of 1 min, and then 2 min, that is 1, 2,3, 4,6,8 and 10 min after the injection; between the samples clotting was prevented, the syringe was rinsed and the first fraction of blood was discarded. The eight blood samples were placed in centrifuge tubes, diluted with 4 ml of physiological saline and centrifuged for 5 min at 2000 g. Any supernatant ring of fat was carefully and evenly distributed in the plasma supernatant with the aid of a glass rod. One millilitre of the supernatant plasma was pipetted and diluted with 2 ml of physiological saline; the turbidity of the plasma was compared with that of the reference sample in a spectrophotometer at 578 nm.
Fat particle clearance is an exponential function; the quantity phagocytosed in unit time is proportional to the concentration in the plasma. In order to obtain a straight line, the decay curve values for the individual samples were plotted on semilogarithmic paper. The half-life (Tj) of the lipid droplets in the blood was obtained by extending the clearance line to its intersection with the ordinate, drawing a horizontal line to meet the clearance line through half of the decay and dropping a perpendicular to the abscissa from this point.
Statistical analysis
The t test for comparing two mean values of related samples was used in analysing and assessing the values recorded before and after operation.
The results for the halothane and NLA groups were analysed with the aid of the Mann-Whitney U test.
RESULTS
The 30 patients were all male, the average age being 42.5 yr. Twenty-two were suffering from gastrointestinal disorders, two from inguinal hernia, two had urological disorders and four were undergoing late surgical treatment of a fracture.
In group A (table I) the mean age was 41 yr. Twelve patients received thiopentone, halothane and nitrous oxide, while patients 9, 14 and 15 received etomidate, fentanyl, halothane and nitrous oxide. The average duration of anaesthesia was 2.2 h.
In group B (table II) the mean age was 44 yr. All 15 patients received etomidate, fentanyl and DHB. The mean duration of anaesthesia was 2.6 h.
The clearance values for group A show an increase in T i} suggesting a reduction in the phagocytic activity of the RES, in 11 patients. The most pronounced reduction in phagocytosis occurred in patient 10, in whom T i increased from 2.8 min before anaesthesia to 6.1 min after anaesthesia. T i values before and after the anaesthesia were unchanged in four patients. Of the three patients who received etomidate, fentanyl and halothane, two showed depression of the RES after the anaesthesia and one had identical 7^ values before and after anaesthesia (patient 14).
The results for group B show that T t values were unchanged before and after the anaesthesia in 12 patients. In three patients T^ had decreased after anaesthesia.
Comparison of the mean T i values before and after anaesthesia shows that in group A the mean T± was 2.4 min before anaesthesia and 3.2 min after anaesthesia (P<0.001). In group B the mean T± was 3.1 min before and 2.9 min after anaesthesia {P = 0.25). The difference between the effects of the two methods of anaesthesia was highly significant (P< 0.005).
DISCUSSION
The development of the Lipofundin clearance test (Lemperle and Reichelt, 1973) , which assesses phagocytic activity of RES rather than hepatic circulation (Lemperle, Denk and Reichelt, 1971) , has made it possible to evaluate the RES to gauge the body's state of immunity. The half-life values (7^), in our method, are the times taken for 50% of a fat emulsion administered by rapid i.v. injection to clear 1  1  2  4  1  2  2  7  2  3  2  2  2   25  40  30  50  05  05  40  15  40  40  05  00  25  50  50   3  2  2  1  3  2  2  4  2  3  1  2  2  2  1   50  50  20  15  15  30  30  30  30  00  55  50  30  10  15   3 09  2 56   2 36 from the plasma. The results of previous investigations (Lemperle, Denk and Reichelt, 1971; Lofstrom and Schildt, 1974) have shown that anaesthesia causes inhibition of the phagocytic activity of the RES. We attempted to measure phagocytic activity before and immediately after termination of anaesthesia to eliminate, as far as possible, any effect of the recovery phase.
A marked reduction of the RES activity was observed in 11 of the 15 patients who received halothane-nitrous oxide anaesthesia. Other authors have demonstrated that halothane and its metabolites cause immunosuppression (Bruce and Wingard, 1971; Mathieu, Di Padua and Kahan, 1972; Mathieu et al., 1973 Mathieu et al., , 1974 Mathieu et al., , 1975 Guttner, Zschiesche and Werner, 1973; Makelainen and Rosenberg, 1974) . However, we did not observe impairment of the RES function in any of the patients who had received NLA, although the operations in both groups were equally severe and the anaesthesia in group B lasted about 30 min longer than in group A. There was even a small increase in the RES function in three patients after NLA.
Since it is known from the literature that both thiopentone and phenobarbitone in therapeutic doses cause immunosuppression (Park and Brody, 1971) , we induced anaesthesia with etomidate in three patients in group A. However, immunosuppression occurred in two of these. We attribute the changes in group A to halothane or nitrous oxide, or both, since the 15 patients in the NLA group all received etomidate and no effect on the RES was observed in any of them. Our findings suggest that the doses of phenobarbitone given to all the patients for premedication were so small as to have no effect.
The criticism of Moudgil and Wade (1976) , of clinical studies which do not permit a separation of the effects of duration and depth of anaesthesia, surgical trauma and length of operation, are met to a large extent in this study.
As it is possible for respiratory depression to occur after NLA, and other investigators have observed that the RES depression occurring during halothane anaesthesia, lasts for up to 6 h (Lemperle, Denk and Reichelt, 1971) , further investigations were performed in which a second Lipofundin clearance test was carried out 6 h after the end of anaesthesia, to study a possible effect of hypoventilation on the immune response. Although the results of these investigations are not reported here, it can be stated that RES depression was present after halothane anaesthesia, but not after NLA. However, there was no clinical evidence of hypoventilation in any of the patients in the study.
It is not possible to deduce either from our investigations or from the results given in the literature Further tests were carried out to determine the effect of Lipofundin on the arterial pressure and the e.c.g. and to investigate the possibility of histamine release by this agent. The parameters used were arterial pressure measured indirectly by the Riva-Rocci method, heart rate, differential blood count, serum cholinesterase activity and a direct test of histamine release. It is known from earlier investigations that an increase in histamine concentration in the plasma and whole blood and a reduction in arterial pressure are significant indications of histamine release (Lorenz et al., 1969 (Lorenz et al., , 1972 Doenicke and Lorenz, 1970; Doenicke et al., 1973) . Changes in the white blood cell count, particularly as regards basophils and eosinophils as a proportion of the total leucocyte count, may also be an indication of histamine release.
However, no important changes occurred in the above measurements and we assume that Lipofundin does not cause histamine release.
whether a high dose of DHB (15-25 mg) exerts a depressant effect on RES activity.
A number of anaesthetists disapprove of NLA involving high doses of DHB because of the resultant side-effects (Doenicke et al., 1964; Dundee, 1965; Morrison, Clark and Dundee, 1970) . Since 1965 we have been using a combination of NLA with a hypnotic in order to avoid the need for high doses of DHB. The hypnotic agent etomidate, which has been undergoing clinical trials since 1972, has no effect on the cardiovascular system and offers a good alternative to barbiturates, propanidid and Althesin, which either exert a cardiodepressant effect or may release histamine (Doenicke, 1973; Doenicke et al., 1973) .
